309 George St
Level 4, Suite 404
Sydney, NSW 2000
Australia
61 2 9159 3719
https://www.echoiq.ai
Sector(s): Technology
Industry: Software - Application
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Andrew Grover | Executive Chairman | 265.2k | N/A | N/A |
Mr. Kimber Rothwell | Chief Executive Officer | N/A | N/A | N/A |
Jacki McAvenna | Chief Financial Officer | N/A | N/A | N/A |
Mr. Philip Woolff | Chief Operating Officer | N/A | N/A | N/A |
Sean Bryceland | Chief Technology Officer | N/A | N/A | N/A |
Prof. David Playford | Chief Medical Officer- Medical Advisory Team | N/A | N/A | N/A |
Mr. Donald L. Fowler | President of Echo IQ USA | N/A | N/A | N/A |
Ms. Jessamyn Sarah Lyons AGIA, B.Com. | Company Secretary | N/A | N/A | N/A |
Echo IQ Limited provides artificial intelligence diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. The company also EchoSolvTM, a software for identification Aortic Stenosis heart condition. It primarily serves physicians and health systems. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.
Echo IQ Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.